Imifoplatin

DB17120InvestigationalSmall molecule

Imifoplatin: Overview.

Chemical structure of Imifoplatin
Formula / weight
C6H16N2O7P2Pt · 485.233 g/mol (avg)
Also known as
(1R,2R)-1,2-cyclohexane-diaminepyrophosphato-platinum(II) · 1,2-cyclohexanediamine pyrophosphatoplatinum(ii), (r,r)- · Cyclohexane-(1r,2r)-diamineplatinum(ii) diphosphate · Cyclohexanediamine pyrophosphatoplatinum(ii), (1r,2r)- · Dihydrogen (sp-4-2)-((1r,2r)-cyclohexane-1,2-diamine-.kappa.2n1,n2)(diphosphato(4)-.kappa.2o1,o3)platinate(2)
Code names
PT-112

Resolves to

Compound
UNIIF5I3T42BXCCAS1339960-28-9
Structure
InChIKeySCMHTXQHAHWVSX-BNTLRKBRSA-LSMILES[Pt++].N[C@@H]1CCCC[C@H]1N.OP([O-])(=O)OP(O)([O-])=O
Targets
P03366gag-pol

What you can answer from here — as of April 23, 2025

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
7Clinical trialsPhase, status and sponsor resolved per trial
Sign in
1+ReferenceStructured and connected to the statements they support
Sign in

Which drugs share a target with Imifoplatin, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In